Australian Clinical Labs Limited (ASX:ACL)
2.620
+0.020 (0.77%)
Sep 8, 2025, 4:10 PM AEST
Australian Clinical Labs Revenue
In the fiscal year ending June 30, 2025, Australian Clinical Labs had annual revenue of 741.27M AUD with 6.45% growth. Australian Clinical Labs had revenue of 372.10M in the half year ending June 30, 2025, with 10.49% growth.
Revenue
741.27M
Revenue Growth
+6.45%
P/S Ratio
0.69
Revenue / Employee
157.72K
Employees
4,700
Market Cap
509.50M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 741.27M | 44.90M | 6.45% |
Jun 30, 2024 | 696.37M | -704.00K | -0.10% |
Jun 30, 2023 | 697.07M | -298.53M | -29.99% |
Jun 30, 2022 | 995.60M | 348.90M | 53.95% |
Jun 30, 2021 | 646.70M | 156.13M | 31.83% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 23.73B |
Pro Medicus | 212.98M |
Cochlear | 2.34B |
Sonic Healthcare | 9.65B |
Ramsay Health Care | 17.79B |
Ansell | 3.06B |
Telix Pharmaceuticals | 1.01B |
Mesoblast | 26.23M |